Recent advances in our understanding of the biology of TNFa-TNFR signaling provide excellent opportunities to design targeted therapies that inhibit the effector arm of T cell immunity while unleashing the immunoregulatory properties of TNFa signaling for the treatment of autoimmune diseases and transplant rejection. Here, TNF is linked to autoimmune disease.